Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling.

Valentinis B, Porcellini S, Asperti C, Cota M, Zhou D, Di Matteo P, Garau G, Zucchelli C, Avanzi NR, Rizzardi GP, Degano M, Musco G, Traversari C.

Int J Mol Sci. 2019 Sep 12;20(18). pii: E4511. doi: 10.3390/ijms20184511.

2.

Transcatheter leadless pacemaker implantation in a patient with failing transvenous pacemaker and total occlusion of superior vena cava.

Dell'Era G, Porcellini S, Boggio E, Prenna E, Gravellone M, Varalda M, Erbetta R, Lio V, Occhetta E, Marino P.

J Cardiovasc Med (Hagerstown). 2018 Sep;19(9):511-512. doi: 10.2459/JCM.0000000000000689. No abstract available.

PMID:
29985798
3.

Is the time between first diagnosis of paroxysmal atrial fibrillation and cryoballoon ablation a predictor of efficacy?

Lunati M, Arena G, Iacopino S, Verlato R, Tondo C, Curnis A, Porcellini S, Sciarra L, Molon G, Senatore G, Leoni L, Perego GB, Rauhe W, Pepi P, Landolina M.

J Cardiovasc Med (Hagerstown). 2018 Aug;19(8):446-452. doi: 10.2459/JCM.0000000000000688.

PMID:
29927782
4.

Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene.

Casucci M, Falcone L, Camisa B, Norelli M, Porcellini S, Stornaiuolo A, Ciceri F, Traversari C, Bordignon C, Bonini C, Bondanza A.

Front Immunol. 2018 Mar 21;9:507. doi: 10.3389/fimmu.2018.00507. eCollection 2018.

5.

Pulmonary Vein Isolation with the Cryoballoon Technique: Feasibility, Procedural Outcomes, and Adoption in the Real World: Data from One Shot Technologies TO Pulmonary Vein Isolation (1STOP) Project.

Padeletti L, Curnis A, Tondo C, Lunati M, Porcellini S, Verlato R, Sciarra L, Senatore G, Catanzariti D, Leoni L, Landolina M, Delise P, Iacopino S, Pieragnoli P, Arena G.

Pacing Clin Electrophysiol. 2017 Jan;40(1):46-56. doi: 10.1111/pace.12975. Epub 2016 Dec 22.

PMID:
27862043
6.

The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.

Porcellini S, Asperti C, Valentinis B, Tiziano E, Mangia P, Bordignon C, Rizzardi GP, Traversari C.

Oncoimmunology. 2015 Jul 1;4(10):e1041700. eCollection 2015 Oct.

7.

Anti-metastatic activity of the tumor vascular targeting agent NGR-TNF.

Di Matteo P, Mangia P, Tiziano E, Valentinis B, Porcellini S, Doglioni C, Sanvito F, Bordignon C, Rizzardi GP, Traversari C.

Clin Exp Metastasis. 2015 Mar;32(3):289-300. doi: 10.1007/s10585-015-9704-7. Epub 2015 Feb 4.

PMID:
25648442
8.

Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase.

Kataropoulou A, Bovolenta C, Belfiore A, Trabatti S, Garbelli A, Porcellini S, Lupo R, Maga G.

Nucleic Acids Res. 2014 Apr;42(6):4144. doi: 10.1093/nar/gku195. Epub 2014 Mar 13. No abstract available.

9.

Therapeutic genes for anti-HIV/AIDS gene therapy.

Bovolenta C, Porcellini S, Alberici L.

Curr Pharm Biotechnol. 2013;14(5):488-500. Review.

PMID:
22429132
10.

Selective preservation of bone marrow mature recirculating but not marginal zone B cells in murine models of chronic inflammation.

Traggiai E, Casati A, Frascoli M, Porcellini S, Ponzoni M, Sanvito F, Leng L, Bucala R, Moretta L, Grassi F.

PLoS One. 2010 Jun 22;5(6):e11262. doi: 10.1371/journal.pone.0011262.

11.

Pacemaker implantation in a patient with persistent left superior vena cava using a steerable catheter-delivered lead.

Porcellini S, Rimini A, Biasi S.

J Cardiovasc Med (Hagerstown). 2012 Oct;13(10):653-5. doi: 10.2459/JCM.0b013e3283389aff. No abstract available.

PMID:
20308913
12.

Chim3 confers survival advantage to CD4+ T cells upon HIV-1 infection by preventing HIV-1 DNA integration and HIV-1-induced G2 cell-cycle delay.

Porcellini S, Gubinelli F, Alberici L, Piovani BM, Rizzardi GP, Bovolenta C.

Blood. 2010 May 20;115(20):4021-9. doi: 10.1182/blood-2009-09-243030. Epub 2010 Mar 10.

PMID:
20220118
13.

Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase.

Kataropoulou A, Bovolenta C, Belfiore A, Trabatti S, Garbelli A, Porcellini S, Lupo R, Maga G.

Nucleic Acids Res. 2009 Jun;37(11):3660-9. doi: 10.1093/nar/gkp226. Epub 2009 Apr 15.

14.

Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design.

Maruggi G, Porcellini S, Facchini G, Perna SK, Cattoglio C, Sartori D, Ambrosi A, Schambach A, Baum C, Bonini C, Bovolenta C, Mavilio F, Recchia A.

Mol Ther. 2009 May;17(5):851-6. doi: 10.1038/mt.2009.51. Epub 2009 Mar 17.

15.

The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration.

Porcellini S, Alberici L, Gubinelli F, Lupo R, Olgiati C, Rizzardi GP, Bovolenta C.

Blood. 2009 Apr 9;113(15):3443-52. doi: 10.1182/blood-2008-06-158790. Epub 2009 Feb 11.

PMID:
19211937
16.

Recombinase-deficient T cell development by selective accumulation of CD3 into lipid rafts.

Ferrera D, Panigada M, Porcellini S, Grassi F.

Eur J Immunol. 2008 Apr;38(4):1148-56. doi: 10.1002/eji.200737917.

17.

EVA regulates thymic stromal organisation and early thymocyte development.

DeMonte L, Porcellini S, Tafi E, Sheridan J, Gordon J, Depreter M, Blair N, Panigada M, Sanvito F, Merati B, Albientz A, Barthlott T, Ozmen L, Blackburn CC, Guttinger M.

Biochem Biophys Res Commun. 2007 May 4;356(2):334-40. Epub 2007 Mar 5.

PMID:
17362876
18.

Regulation of peripheral T cell activation by calreticulin.

Porcellini S, Traggiai E, Schenk U, Ferrera D, Matteoli M, Lanzavecchia A, Michalak M, Grassi F.

J Exp Med. 2006 Feb 20;203(2):461-71.

19.

NKG2D-independent suppression of T cell proliferation by H60 and MICA.

Kriegeskorte AK, Gebhardt FE, Porcellini S, Schiemann M, Stemberger C, Franz TJ, Huster KM, Carayannopoulos LN, Yokoyama WM, Colonna M, Siccardi AG, Bauer S, Busch DH.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11805-10. Epub 2005 Aug 9.

20.

Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.

Porcellini S, Vallanti G, Nozza S, Poli G, Lazzarin A, Tambussi G, Siccardi AG, Grassi F.

AIDS. 2003 Jul 25;17(11):1621-30.

PMID:
12853744
21.

Constitutive endocytosis and degradation of the pre-T cell receptor.

Panigada M, Porcellini S, Barbier E, Hoeflinger S, Cazenave PA, Gu H, Band H, von Boehmer H, Grassi F.

J Exp Med. 2002 Jun 17;195(12):1585-97.

22.

Lack of NO Formation Is Involved in the Vasodilative Response to Contrast Media.

Jun T, Danna P, Piccaluga E, Seregni R, Colombo A, Porcellini S, Viecca M, Florentini C.

Int J Angiol. 2000 Jan;9(1):42-45.

PMID:
10629325
23.

[Bifurcation stenting of unprotected common trunk: a case report and review of the literature].

Danna P, Porcellini S, Viecca M.

G Ital Cardiol. 1999 Oct;29(10):1227-32. Italian.

PMID:
10546140
24.

Molecular and cellular aspects of induced thymus development in recombinase-deficient mice.

Porcellini S, Panigada M, Grassi F.

Eur J Immunol. 1999 Aug;29(8):2476-83.

25.

GKLF in thymus epithelium as a developmentally regulated element of thymocyte-stroma cross-talk.

Panigada M, Porcellini S, Sutti F, Doneda L, Pozzoli O, Consalez GG, Guttinger M, Grassi F.

Mech Dev. 1999 Mar;81(1-2):103-13.

26.

Surface expression and functional competence of CD3-independent TCR zeta-chains in immature thymocytes.

Grassi F, Barbier E, Porcellini S, von Boehmer H, Cazenave PA.

J Immunol. 1999 Mar 1;162(5):2589-96.

27.

Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis.

Guttinger M, Sutti F, Panigada M, Porcellini S, Merati B, Mariani M, Teesalu T, Consalez GG, Grassi F.

J Cell Biol. 1998 May 18;141(4):1061-71.

Supplemental Content

Loading ...
Support Center